ANRO Alto Neuroscience, Inc.
$32.00▲ +1.01%
Healthcare
Other
After hours
$32.00▼ -0.05%
Sep 11, 4:01 PM ET
Volume 415.7K
Avg Volume (10D) 467.6K
Key Metrics & Fundamentals
Market Cap
$1.26B
P/E Ratio
–
Div Yield
–%
52W Range
3.59 - 37.48
% vs 50 MA
5.07%
% vs 200 MA
41.37%
RSI-14
44.8
MACD Histogram
-0.7100
Beta (1Y vs SPY)
2.36
Free Cash Flow
-$19.76M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$26.96M
COGS
–
Operating Exp
$29.13M
Operating Income
-$29.13M
EBIT
-$29.13M
Pretax Income
-$27.64M
Net Income
-$27.64M
EPS (Diluted)
-0.65
Price & Volume History
Loading chart…
Recent News
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Business Wire · Sep 9, 2026 12:03 PM
Alto Neuroscience Promotes Nick Smith to President and CFO
MT Newswires · Aug 27, 2026 9:12 PM
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
Business Wire · Aug 27, 2026 8:05 PM
Alto Neuroscience (ANRO) Reports Another Quarterly Loss, Is The Stock Already Overvalued?
Simply Wall St. · Aug 16, 2026 8:07 PM
Are Alto Neuroscience’s (ANRO) Rising Losses Funding a Stronger Depression Pipeline or Diluting Discipline?
Simply Wall St. · Aug 16, 2026 8:08 AM
Alto Neuroscience (ANRO) Stock Looks Stretched On Expanded ALTO 207 Plans
Simply Wall St. · Aug 16, 2026 3:16 AM
BofA Adjusts Price Target on Alto Neuroscience to $37 From $33
MT Newswires · Aug 14, 2026 11:35 AM
Wedbush Adjusts Price Target on Alto Neuroscience to $26 From $24, Keeps Neutral Rating
MT Newswires · Aug 13, 2026 10:50 AM
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Business Wire · Aug 12, 2026 8:03 PM
Alto Neuroscience Prices $100 Million Stock Offering
MT Newswires · Jul 13, 2026 12:22 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ANRO's money flow as a full page
Social Sentiment
No Reddit posts found for ANRO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.